Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Obstet Gynaecol Res ; 48(9): 2334-2344, 2022 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-35732592

RESUMO

AIM: Pulmonary embolism remains a leading cause of maternal mortality in developed countries despite developments in venous thromboembolism prophylaxis strategies. This study aimed to evaluate the effectiveness of our approach involving risk-scoring, D-dimer level assessment, and ultrasonography for obstetric venous thromboembolism. METHODS: This retrospective cohort study included women who delivered at 22-41 weeks of gestation in The University of Tsukuba Hospital, Japan between January and December 2020. Venous thromboembolism risk (determined according to Japanese guidelines) and D-dimer levels were evaluated within 20 weeks of gestation, 30-34 weeks of gestation, and during the pre-delivery period (36 weeks of gestation or any time before preterm delivery). Compression and color Doppler ultrasonography for lower extremity deep vein thrombosis were performed if D-dimer levels were ≥3.2 µg/mL (for those undergoing cesarean delivery, 1.0 µg/mL). RESULTS: Of 1026 women, 6 women had deep vein thrombosis during pregnancy and 1 during the puerperium period. Pulmonary embolism was not observed. The D-dimer screening result was positive for 8 women (2%) within 20 weeks of gestation (deep vein thrombosis was confirmed in 3 of them), 87 women (10%) (no deep vein thrombosis) at 30-34 weeks of gestation, and 367 women (36%) during the pre-delivery period (asymptomatic deep vein thrombosis in one). Based on the Japanese guidelines, 1%, 11%, 33%, and 55% of women had high, intermediate, low, and no postpartum risk factors, respectively. CONCLUSIONS: Our approach appears useful for antenatal venous thromboembolism screening in the first trimester. For postpartum prophylaxis, more cost-effective strategies are needed.


Assuntos
Embolia Pulmonar , Tromboembolia Venosa , Trombose Venosa , Feminino , Produtos de Degradação da Fibrina e do Fibrinogênio , Humanos , Recém-Nascido , Japão/epidemiologia , Gravidez , Embolia Pulmonar/diagnóstico por imagem , Embolia Pulmonar/prevenção & controle , Estudos Retrospectivos , Fatores de Risco , Centros de Atenção Terciária , Ultrassonografia , Tromboembolia Venosa/diagnóstico por imagem , Tromboembolia Venosa/prevenção & controle , Trombose Venosa/diagnóstico por imagem , Trombose Venosa/prevenção & controle
2.
J Obstet Gynaecol Res ; 45(6): 1127-1133, 2019 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-30788889

RESUMO

AIM: Post-partum hematomas are a serious obstetrical complication. Choosing treatments for post-partum hematomas is difficult, and the application of transcatheter arterial embolization remains unclear. We aimed to clarify the clinical characteristics, identify the treatment indications and create a treatment algorithm for post-partum hematomas. METHODS: Fifty-four patients with post-partum hematomas were enrolled. Hematomas were categorized according to location: upper vaginal, lower vaginal and vulvar. Blood loss, treatment methods and other clinical data were collected from the patients' medical records and analyzed retrospectively. RESULTS: Five, 19 and 30 patients had upper vaginal wall, lower vaginal wall and vulvar hematomas, respectively. All upper vaginal wall hematomas required transcatheter arterial embolization to control bleeding, and the average blood loss was 2473 ± 1689 mL. Most lower vaginal wall hematomas were treated surgically; however, two patients required transcatheter arterial embolization, and the average blood loss in these patients was much higher (2010 ± 1145 mL) than that in patients with lower vaginal wall hematomas (395 ± 316 mL). No patient with vulvar hematomas was treated with transcatheter arterial embolization. Two and four patients with vulvar and lower vaginal wall hematomas, respectively, were managed with observation. CONCLUSION: We created an algorithm for post-partum hematoma management. Post-partum hematoma location should guide treatment selection. Transcatheter arterial embolization should be selected for upper vaginal wall hematomas. Most lower vaginal wall hematomas are treatable with surgery, but transcatheter arterial embolization should be considered for hemostasis in difficult cases. Management with observation may also be possible for lower vaginal wall and vulvar hematomas.


Assuntos
Algoritmos , Embolização Terapêutica/métodos , Procedimentos Cirúrgicos em Ginecologia/métodos , Hematoma/terapia , Complicações do Trabalho de Parto/terapia , Transtornos Puerperais/terapia , Doenças Vaginais/terapia , Doenças da Vulva/terapia , Adulto , Feminino , Hematoma/etiologia , Humanos , Gravidez , Transtornos Puerperais/etiologia , Doenças Vaginais/etiologia , Doenças da Vulva/etiologia
3.
J Perinat Med ; 44(5): 551-6, 2016 Jul 01.
Artigo em Inglês | MEDLINE | ID: mdl-26756085

RESUMO

AIMS: This study aimed to determine effective predictive factors for primary postpartum hemorrhage (PPH) among clinical blood parameters associated with coagulation and fibrinolysis and demographic characteristics. METHODS: We retrospectively studied 1032 women who underwent determinations of clinical blood parameters at gestational week (GW) 29-32 and GW 35-37 and gave birth to singleton infants at our hospital between January 2011 and December 2013. PPH was defined as estimated blood loss ≥700 mL. Multivariate logistic regression analyses were used to determine independent risk factors and odds ratios (OR) for PPH. RESULTS: PPH occurred in 104 of 1032 women (10%). Three blood variables, fibrinogen level <4.0 g/L (OR [95% CI], 1.96 [1.18-3.27]), antithrombin activity <85% of normal activity level (1.84 [1.05-3.21]), and D-dimer level >2.7 µg/mL (2.03 [1.29-3.19]) at GW 35-37, and three demographic characteristics, maternal age ≥35 years (1.75 [1.15-2.68]), BMI >28.2 kg/m2 on admission for childbirth (1.95 [1.20-3.16]), and previous cesarean delivery (2.77 [1.31-5.83]), were identified as independent risk factors for PPH. CONCLUSION: Among blood parameters, higher D-dimer levels and lower levels of antithrombin activity and fibrinogen in late gestation were independent risk factors for PPH.


Assuntos
Produtos de Degradação da Fibrina e do Fibrinogênio/metabolismo , Hemorragia Pós-Parto/sangue , Hemorragia Pós-Parto/etiologia , Terceiro Trimestre da Gravidez/sangue , Adolescente , Adulto , Antitrombinas/sangue , Biomarcadores/sangue , Índice de Massa Corporal , Cesárea , Feminino , Fibrinogênio/metabolismo , Humanos , Recém-Nascido , Masculino , Idade Materna , Pessoa de Meia-Idade , Valor Preditivo dos Testes , Gravidez , Estudos Retrospectivos , Fatores de Risco , Adulto Jovem
4.
J Obstet Gynaecol Res ; 39(1): 344-6, 2013 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-22765395

RESUMO

We here report the first case of discordant Pena-Shokeir phenotype observed in monoamniotic twins. A 34-year-old woman, pregnant with twins, was referred at 10 weeks' gestation because one of the twins had increased nuchal translucency. Serial ultrasonographic examinations suggested that twin A may have had several other abnormalities, including pleural effusion at 21 weeks' gestation, decreased movement and contracted limbs at 24 weeks, and fetal growth restriction at 26 weeks. No abnormalities were observed in twin B. At 34 weeks of gestation, the twins were delivered by cesarean section. There were cord entanglements, and although the resuscitation of twin A was attempted, it proved difficult due to lockjaw. Twin A died during the second hour of life, and autopsy findings were consistent with the diagnosis of Pena-Shokeir phenotype. We suggest that cord entanglement during early gestation is a possible cause for the occurrence of Pena-Shokeir phenotype through an anoxic-ischemic mechanism.


Assuntos
Anormalidades Múltiplas/diagnóstico por imagem , Artrogripose/diagnóstico por imagem , Retardo do Crescimento Fetal/diagnóstico por imagem , Derrame Pleural/diagnóstico por imagem , Gêmeos Monozigóticos , Cesárea , Evolução Fatal , Feminino , Idade Gestacional , Humanos , Gravidez , Ultrassonografia Pré-Natal
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...